Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sphingosine kinase 1 (SphK1) is a lipid kinase enzyme that catalyzes the phosphorylation of sphingosine to produce sphingosine-1-phosphate (S1P), a potent bioactive lipid mediator. It plays a critical role in regulating cell survival, proliferation, differentiation, migration, and immune function. SphK1 is implicated in various diseases, including cancer, inflammation, and metabolic disorders, making it a potential therapeutic target. Selective inhibitors like SKI-I have shown promise in preclinical studies.
Inhibition of SphK1, leading to decreased S1P production and increased ceramide/sphingosine levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sphingosine kinase 1 (SphK1).